StonvexLoading…
StonvexStonvexStonvexCore line items from RUN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.96B | $2.04B | $2.26B | $2.32B |
Operating Income | $-126.13M | $-3.70B | $-1.98B | $-662.19M |
Net Income | $449.95M | $-2.85B | $-1.60B | $173.38M |
EPS (Diluted) | $1.71 | $-12.81 | $-7.41 | $0.80 |
Total Assets | $22.61B | $19.90B | $20.45B | $19.27B |
Total Liabilities | $17.63B | $15.73B | $13.54B | $11.09B |
Cash & Equivalents | $1.24B | $947.42M | $987.84M | $953.02M |
Free Cash Flow OCF − CapEx | Not available | $-767.73M | $-841.70M | $-867.00M |
Shares Outstanding | 233.61M | 225.66M | 219.39M | 214.18M |